IM Cannabis Corp C.IMCC

Alternate Symbol(s): IMCC

Healthcare

IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which has a cultivation license to breed, grow and supply medical cannabis products in Israel. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in Israel. The Company operates through Adjupharm GmbH in Europe, which is a medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits. The Company operates through Trichome and its subsidiaries Trichome JWC Acquisition Corp. and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.

CSE:IMCC - Post by User

IM Cannabis Corp

Bullboard Posts

Post by LatAmBullon Apr 13, 2020 11:15am

139 Views

Post# 30903074

IMC Announces Three-Year CAD$80.4 Million Sales Agreement

Massive announcement to Super Pharm, which is the Shoppers Drug Mart of Israel.

The market cap is ~$32 million and the Company has ~$12 million in cash (therefore enterprise value of ~$20 million). This contract alone will have gross profit of ~$40 million over the next three years.

In addition to other sales agreements and EU/German opportunity, this stock is significantly undervalued.

https://webfiles.thecse.com/04.13.2020_Cision_Final.pdfjqo9D2UAIhGvDfNhECnYkJYyoSB2NxKy

Bullboard Posts

Nine Mile Metals completes acquisition of 3 properties